1.Outcomes of Lung Transplantation for Bronchiolitis Obliterans after Hematopoietic Stem Cell Transplantation Compared with Those for Idiopathic Pulmonary Fibrosis
Bong Suk PARK ; Ha Eun KIM ; Young Ho YANG ; Dae Joon KIM ; Chang Young LEE ; Byung Jo PARK ; A La WOO ; Eun Young KIM ; Moo Suk PARK ; Song Yee KIM ; Jin Gu LEE
Yonsei Medical Journal 2026;67(1):27-33
Purpose:
Bronchiolitis obliterans syndrome (BOS) can develop as a manifestation of graft-versus-host disease following allogeneic hematopoietic stem cell transplantation (allo-HSCT), and may ultimately require lung transplantation (LT). However, reports on LT outcomes for BOS after allo-HSCT are limited. This study aimed to compare the outcomes of LT for BOS following allo-HSCT with those for idiopathic pulmonary fibrosis (IPF).
Materials and Methods:
A total of 487 patients underwent LT between January 2010 and August 2023. Among them, the baseline characteristics and outcomes of 35 patients with BOS following allo-HSCT and 216 patients with IPF were analyzed.
Results:
The BOS group was younger and had a lower body mass index (BMI) compared to the IPF group (33.7±11.9 years vs.59.7±7.3 years, p<0.001; 17.6±3.7 kg/m2 vs. 22.0±3.6 kg/m2 , p<0.001, respectively). The proportion of male patients was lower in the BOS group than in the IPF group (54.3% vs. 84.3%, p<0.001). Preoperative ventilator support was more common in the BOS group compared to the IPF group (62.9% vs. 32.4%, p=0.001). In Kaplan–Meier survival analysis, the 5-year survival rate was significantly higher in the BOS group than in the IPF group (71.0% vs. 44.9%, p=0.022). In the Cox proportional hazards model, age was the only factor significantly associated with survival [hazard ratio (95% confidence interval): 1.04 (1.02–1.07), p<0.001].
Conclusion
The survival rate of the BOS group was not inferior to that of the IPF group after adjusting for sex, age, and BMI. Therefore, LT should be actively considered as a treatment option for patients with BOS following allo-HSCT.
2.Tumor-Associated Macrophage Infiltration and PD-L1 Expression in Gastric Cancer According to a Modified TCGA-Based Classification
Boram SONG ; Dong-Hoe KOO ; Eo Jin KIM ; In-Gu DO ; Jinah CHU ; Kyungeun KIM ; Hyebin LEE ; Min-Jung KWON ; Jung Ho PARK ; Byung Ho SON ; Chang Hak YOO ; Seoung Wan CHAE
Journal of Gastric Cancer 2026;26(2):247-259
Purpose:
Although gastric cancer (GC) exhibits significant genomic heterogeneity, the clinical implications of its immune microenvironment remain poorly understood.
Materials and Methods:
We retrospectively evaluated patients with GC who underwent gastrectomies between 2011 and 2014. The tumors were analyzed for Epstein–Barr virus (EBV), microsatellite instability-high (MSI-H), tumor-infiltrating lymphocytes (CD3), tumor-associated macrophages (CD68 and CD163), and programmed death-ligand 1 (PD-L1) expression. Tumors were classified using the modified The Cancer Genome Atlas scheme, and their clinical characteristics were compared.
Results:
A total of 567 patients were classified into EBV (6%), MSI-H (10%), chromosomal instability-like (36%), and genomically stable-like (48%) subtypes. EBV tumors exhibited the highest PD-L1 expression (85%) and immune infiltration by CD3+ T cells (86%), CD68+ macrophages (58%), and CD163+ macrophages (40%). High CD68+ macrophage tumors were associated with advanced stages and worse 5-year disease-free survival (83% vs. 95%; P<0.001);however, this association was not independently significant after adjusting for the tumor-nodemetastasis stage. PD-L1 expression did not significantly affect the survival outcomes.
Conclusions
GC subtypes have distinct immune microenvironments that influence prognosis. Our findings highlight the prognostic and therapeutic potential of immune profiling in GC.
3.Stress Accelerates Depressive-Like Behaviors through Increase of Notch2 Expression in N141I Mutation Presenilin-2 Transgenic Mice
Seung Sik YOO ; Sun Mi GU ; Kyung Tak NAM ; Jeong Soon CHOI ; Yong Sun LEE ; In Jun YEO ; Ji Eun YU ; Sanghyeon KIM ; Dong Won LEE ; Hyeon Joo HAM ; Ju Young CHANG ; Jaesuk YUN ; Dong Ju SON ; Sang-Bae HAN ; Jin Tae HONG
Biomolecules & Therapeutics 2026;34(3):544-555
Alzheimer’s disease (AD) is characterized by progressive cognitive deterioration and significant depression. However, the mechanisms linking depression to AD pathology remain unclear. Here, we investigated whether Notch2 signaling mediates depressionlike behaviors in presenilin-2 (PS2) N141I mutant mice, an early-onset AD model. PS2 wild-type (WT) and mutant (MT) mice aged 12-15 months were subjected to unpredictable chronic mild stress (UCMS) for 4 weeks, followed by sucrose preference, tail-hanging, and forced swimming tests. Behavioral assessments showed that UCMS exacerbated anhedonia and immobility only in PS2 MT mice. Molecular analysis revealed concomitant increases in plasma corticosterone, hippocampal γ-secretase activity, and Notch2 expression, and elevated total and phosphorylated glucocorticoid receptor levels in PS2 MT-UCMS mice. Gene expression profiling of human hippocampal datasets confirmed upregulation of NOTCH2 in Alzheimer’s disease and depression.Pharmacological inhibition of γ-secretase and Notch signaling with DAPT normalizes depressive behavior, reduces corticosterone release, attenuates GR phosphorylation, and inhibits Notch2 signaling in PS2 MT mice. These findings identify Notch2 as a pivotal mediator linking chronic stress to molecular changes associated with depression and AD, and suggest that targeting Notch2 signaling may provide therapeutic benefits for comorbid mood and neurodegenerative disorders.
4.Postoperative Readmission Is Associated With Worse Oncologic Outcomes After Radical Cystectomy for Bladder Cancer: A Multicenter Study of 3,972 Patients
Jungwon PARK ; Jong Ho PARK ; Sangchul LEE ; Seung-Hwan JEONG ; Ja Hyeon KU ; Kyung Hwan KIM ; Jong Kil NAM ; Bumjin LIM ; BumSik HONG ; Wook NAM ; Sung Gu KANG ; Seok Ho KANG ; Tae Gyun KWON ; Tae-Hwan KIM ; Jieun HEO ; Won Sik HAM ; Geehyun SONG ; Ho Kyung SEO ; Wan SONG ; Hyun Hwan SUNG ; Byong Chang JEONG ; Jong Jin OH
Journal of Urologic Oncology 2026;24(1):69-78
Purpose:
Radical cystectomy (RC) is associated with substantial postoperative morbidity, and unplanned readmission remains common despite advances in perioperative management. However, the association between postoperative readmission due to complications and oncologic outcomes after RC for bladder cancer has not been clearly defined. We evaluated the impact of postoperative readmission on overall survival (OS) and cancer-specific survival (CSS) after RC for bladder cancer.
Materials and Methods:
We retrospectively analyzed 3,972 patients who underwent RC for bladder cancer in a multicenter cohort. Postoperative readmission was defined as unplanned hospitalization within 90 days postsurgery due to surgery-related complications. Survival outcomes were assessed using the Kaplan-Meier method and compared using the log-rank test. Univariable and multivariable Cox proportional hazards regression analyses were performed to identify independent predictors of OS and CSS.
Results:
Among the study population, 916 patients (23.1%) experienced postoperative readmission. Baseline and perioperative characteristics were generally comparable between patients with and without readmission. Kaplan-Meier analyses demonstrated significantly worse OS and CSS among patients who experienced postoperative readmission (both log-rank p<0.001). In multivariable analyses adjusting for clinicopathological factors, postoperative readmission remained independently associated with worse OS (hazard ratio [HR], 1.654; 95% confidence interval [CI], 1.464–1.868; p<0.001) and CSS (HR, 1.761; 95% CI, 1.509–2.055; p<0.001).
Conclusion
Postoperative readmission within 90 days after RC was independently associated with inferior long-term oncologic outcomes. These findings suggest the importance of strategies aimed at preventing postoperative complications and subsequent readmission.
5.Effect of Kangxian Yixin Prescription on Cardiac Function and Myocardial Fibroblasts in Dilated Cardiomyopathy Rats
Chuiyi ZENG ; Zhentao WANG ; Huichao ZHANG ; Hongbo CHANG ; Bing WANG ; Suting GU ; Shujuan ZHANG
Chinese Journal of Experimental Traditional Medical Formulae 2026;32(21):86-98
ObjectiveTo investigate the mechanism by which Kangxian Yixin prescription regulates the circular RNA 0006719 (circ0006719)/microRNA 6852-5p (miR-6852-5p)/transforming growth factor-β1 (TGF-β1)/Smad axis to ameliorate myocardial fibrosis in rats with dilated cardiomyopathy (DCM) and angiotensin Ⅱ (Ang Ⅱ)-induced activation of cardiac fibroblasts (CFs). MethodsA DCM rat model was established by administration of furazolidone. The rats were divided into normal group, model group, captopril (CAP, 10.1 mg·kg-1·d-1) group, and low-, medium-, and high-dose Kangxian Yixin prescription groups (0.9, 1.8, 3.6 g·kg-1·d-1), with 15 rats in each group. After modeling, the treatment groups received corresponding drug solutions by gavage, whereas the normal and model groups received an equal volume of normal saline for 60 consecutive days. Echocardiography was used to measure left ventricular end-systolic diameter (LVESD), left ventricular end-diastolic diameter (LVEDD), left ventricular ejection fraction (LVEF), and left ventricular fractional shortening (LVFS). Transmission electron microscopy (TEM), hematoxylin-eosin (HE) staining, and Masson staining were used to observe myocardial ultrastructure, pathological changes, and collagen deposition. Immunohistochemistry (IHC) was used to detect the protein expression of collagen type Ⅰ alpha 1 (Col1A1) and collagen type Ⅲ(Col Ⅲ) in myocardial tissue. Real-time quantitative polymerase chain reaction (Real-time PCR), Western blot, and fluorescence in situ hybridization (FISH) were used to detect the expression and localization of circ0006719, miR-6852-5p, fibrosis-related molecules, and TGF-β1/Smad pathway-related molecules in myocardial tissue and CFs. CFs from neonatal rats were isolated and cultured in vitro. Cell Counting Kit-8 (CCK-8) assay was used to determine the optimal concentration of Kangxian Yixin prescription for subsequent intervention. An Ang Ⅱ-induced CF activation model was established, and the cells were divided into normal group, Ang Ⅱ group, Ang Ⅱ+CAP group, Ang Ⅱ+Kangxian Yixin prescription group, and Ang Ⅱ+Kangxian Yixin prescription+miR-6852-5p inhibitor group. CF viability and fibrosis-related molecular expression were detected. RNA immunoprecipitation (RNA IP) and dual-luciferase reporter assays were used to verify the targeting relationship between circ0006719 and miR-6852-5p. ResultsCompared with the normal group, the model group showed significantly increased LVESD and LVEDD, significantly decreased LVEF and LVFS, aggravated myocardial ultrastructural and histopathological injury, and significantly increased collagen volume fraction (CVF) in myocardial tissue (P<0.01). The expression of circ0006719, Col1A1 mRNA, Col ⅢmRNA, and Col1A1, Col Ⅲ, TGF-β1, Smad3, and Smad4 proteins in myocardial tissue was significantly upregulated, whereas miR-6852-5p expression and Smad7 protein expression were significantly downregulated (P<0.01). Compared with the model group, the CAP group and the high- and medium-dose Kangxian Yixin prescription groups showed varying degrees of improvement in cardiac function, myocardial fibrosis, circ0006719/miR-6852-5p expression, and TGF-β1/Smad pathway-related indicators, with more pronounced improvements in the CAP group and the high-dose Kangxian Yixin prescription group (P<0.05, P<0.01). In in vitro experiments, 2.0 g·L-1 was determined as the optimal concentration of Kangxian Yixin prescription for subsequent intervention. Compared with the normal group, the Ang Ⅱ group showed significantly increased CF viability, significantly upregulated expression of circ0006719, Col1A1 mRNA, α-smooth muscle actin (α-SMA) mRNA, and Col1A1, α-SMA, TGF-β1, Smad3, and Smad4 proteins in CFs, and significantly downregulated miR-6852-5p expression and Smad7 protein expression (P<0.01). Compared with the Ang Ⅱ group, the Ang Ⅱ+CAP group and the Ang Ⅱ+Kangxian Yixin prescription group showed markedly decreased CF viability and fibrosis-related mRNA and protein expression, markedly increased miR-6852-5p expression, and markedly attenuated TGF-β1/Smad pathway activation (P<0.05, P<0.01). Compared with the Ang Ⅱ+Kangxian Yixin prescription group, the Ang Ⅱ+Kangxian Yixin prescription+miR-6852-5p inhibitor group showed significantly increased CF viability (P<0.01), markedly increased expression of circ0006719, Col1A1 mRNA, and Col1A1, TGF-β1, and Smad4 proteins in CFs, and markedly decreased miR-6852-5p expression (P<0.05, P<0.01). RNA IP and dual-luciferase reporter assays showed a targeting binding relationship between circ0006719 and miR-6852-5p (P<0.01). ConclusionKangxian Yixin prescription may alleviate myocardial collagen deposition and myocardial fibrosis, improve cardiac function in DCM rats, and inhibit Ang Ⅱ-induced abnormal activation of CFs. Its mechanism may be associated with downregulation of circ0006719, restoration of miR-6852-5p expression, and inhibition of the TGF-β1/Smad pathway.
6.Effect of Kangxian Yixin Prescription on Cardiac Function and Myocardial Fibroblasts in Dilated Cardiomyopathy Rats
Chuiyi ZENG ; Zhentao WANG ; Huichao ZHANG ; Hongbo CHANG ; Bing WANG ; Suting GU ; Shujuan ZHANG
Chinese Journal of Experimental Traditional Medical Formulae 2026;32(21):86-98
ObjectiveTo investigate the mechanism by which Kangxian Yixin prescription regulates the circular RNA 0006719 (circ0006719)/microRNA 6852-5p (miR-6852-5p)/transforming growth factor-β1 (TGF-β1)/Smad axis to ameliorate myocardial fibrosis in rats with dilated cardiomyopathy (DCM) and angiotensin Ⅱ (Ang Ⅱ)-induced activation of cardiac fibroblasts (CFs). MethodsA DCM rat model was established by administration of furazolidone. The rats were divided into normal group, model group, captopril (CAP, 10.1 mg·kg-1·d-1) group, and low-, medium-, and high-dose Kangxian Yixin prescription groups (0.9, 1.8, 3.6 g·kg-1·d-1), with 15 rats in each group. After modeling, the treatment groups received corresponding drug solutions by gavage, whereas the normal and model groups received an equal volume of normal saline for 60 consecutive days. Echocardiography was used to measure left ventricular end-systolic diameter (LVESD), left ventricular end-diastolic diameter (LVEDD), left ventricular ejection fraction (LVEF), and left ventricular fractional shortening (LVFS). Transmission electron microscopy (TEM), hematoxylin-eosin (HE) staining, and Masson staining were used to observe myocardial ultrastructure, pathological changes, and collagen deposition. Immunohistochemistry (IHC) was used to detect the protein expression of collagen type Ⅰ alpha 1 (Col1A1) and collagen type Ⅲ(Col Ⅲ) in myocardial tissue. Real-time quantitative polymerase chain reaction (Real-time PCR), Western blot, and fluorescence in situ hybridization (FISH) were used to detect the expression and localization of circ0006719, miR-6852-5p, fibrosis-related molecules, and TGF-β1/Smad pathway-related molecules in myocardial tissue and CFs. CFs from neonatal rats were isolated and cultured in vitro. Cell Counting Kit-8 (CCK-8) assay was used to determine the optimal concentration of Kangxian Yixin prescription for subsequent intervention. An Ang Ⅱ-induced CF activation model was established, and the cells were divided into normal group, Ang Ⅱ group, Ang Ⅱ+CAP group, Ang Ⅱ+Kangxian Yixin prescription group, and Ang Ⅱ+Kangxian Yixin prescription+miR-6852-5p inhibitor group. CF viability and fibrosis-related molecular expression were detected. RNA immunoprecipitation (RNA IP) and dual-luciferase reporter assays were used to verify the targeting relationship between circ0006719 and miR-6852-5p. ResultsCompared with the normal group, the model group showed significantly increased LVESD and LVEDD, significantly decreased LVEF and LVFS, aggravated myocardial ultrastructural and histopathological injury, and significantly increased collagen volume fraction (CVF) in myocardial tissue (P<0.01). The expression of circ0006719, Col1A1 mRNA, Col ⅢmRNA, and Col1A1, Col Ⅲ, TGF-β1, Smad3, and Smad4 proteins in myocardial tissue was significantly upregulated, whereas miR-6852-5p expression and Smad7 protein expression were significantly downregulated (P<0.01). Compared with the model group, the CAP group and the high- and medium-dose Kangxian Yixin prescription groups showed varying degrees of improvement in cardiac function, myocardial fibrosis, circ0006719/miR-6852-5p expression, and TGF-β1/Smad pathway-related indicators, with more pronounced improvements in the CAP group and the high-dose Kangxian Yixin prescription group (P<0.05, P<0.01). In in vitro experiments, 2.0 g·L-1 was determined as the optimal concentration of Kangxian Yixin prescription for subsequent intervention. Compared with the normal group, the Ang Ⅱ group showed significantly increased CF viability, significantly upregulated expression of circ0006719, Col1A1 mRNA, α-smooth muscle actin (α-SMA) mRNA, and Col1A1, α-SMA, TGF-β1, Smad3, and Smad4 proteins in CFs, and significantly downregulated miR-6852-5p expression and Smad7 protein expression (P<0.01). Compared with the Ang Ⅱ group, the Ang Ⅱ+CAP group and the Ang Ⅱ+Kangxian Yixin prescription group showed markedly decreased CF viability and fibrosis-related mRNA and protein expression, markedly increased miR-6852-5p expression, and markedly attenuated TGF-β1/Smad pathway activation (P<0.05, P<0.01). Compared with the Ang Ⅱ+Kangxian Yixin prescription group, the Ang Ⅱ+Kangxian Yixin prescription+miR-6852-5p inhibitor group showed significantly increased CF viability (P<0.01), markedly increased expression of circ0006719, Col1A1 mRNA, and Col1A1, TGF-β1, and Smad4 proteins in CFs, and markedly decreased miR-6852-5p expression (P<0.05, P<0.01). RNA IP and dual-luciferase reporter assays showed a targeting binding relationship between circ0006719 and miR-6852-5p (P<0.01). ConclusionKangxian Yixin prescription may alleviate myocardial collagen deposition and myocardial fibrosis, improve cardiac function in DCM rats, and inhibit Ang Ⅱ-induced abnormal activation of CFs. Its mechanism may be associated with downregulation of circ0006719, restoration of miR-6852-5p expression, and inhibition of the TGF-β1/Smad pathway.
7.A Study of Rhegmatogenous Retinal Detachment in Patients in their 20s
Chang Yoon HAN ; Hyeong Seok KIM ; Young Ju LEW ; Chul Gu KIM ; Jong Woo KIM ; Sae Mi PARK
Journal of the Korean Ophthalmological Society 2025;66(3):158-163
Purpose:
To evaluate the characteristics, anatomical success rate, and factors that may affect the anatomical success of rhegmatogenous retinal detachment in patients in their 20s.
Methods:
We retrospectively analyzed the medical records of patients aged 20-29 years who underwent surgery for rhegmatogenous retinal detachment from January 2018 to December 2022. We examined factors such as sex, age, duration of illness, preoperative best corrected visual acuity, presence of underlying diseases, proliferative vitreoretinopathy, lattice degeneration, macular involvement, extent of retinal detachment at diagnosis, axial length, and myopia level to explore their impact on surgical outcomes.
Results:
The study included 122 eyes. The mean age was 23.81 ± 2.82 years, and the average sphere power was -5.80 ± 3.71 diopters (D). The percentage of eyes with a refraction of ≤ -6.0 D came to 44.3% (54/122), and with ≤ -4.0 D it amounted to 72.1% (88/122). The average logarithm of the minimum angle of resolution (logMAR) best corrected visual acuity improved significantly from 0.52 ± 0.68 before surgery to 0.28 ± 0.45 after surgery. The primary surgical success rates were 92.0% for scleral buckling, 88.9% for vitrectomy, and 92.3% for combined scleral buckling and vitrectomy, with no significant factors related to anatomical success identified.
Conclusions
There was a high prevalence of moderate to severe myopia among patients in their 20s with rhegmatogenous retinal detachment. However, no statistically significant correlation was found between the degree of myopia and anatomical success. Both functional and anatomical outcomes were generally favorable in these patients.
8.A Study of Rhegmatogenous Retinal Detachment in Patients in their 20s
Chang Yoon HAN ; Hyeong Seok KIM ; Young Ju LEW ; Chul Gu KIM ; Jong Woo KIM ; Sae Mi PARK
Journal of the Korean Ophthalmological Society 2025;66(3):158-163
Purpose:
To evaluate the characteristics, anatomical success rate, and factors that may affect the anatomical success of rhegmatogenous retinal detachment in patients in their 20s.
Methods:
We retrospectively analyzed the medical records of patients aged 20-29 years who underwent surgery for rhegmatogenous retinal detachment from January 2018 to December 2022. We examined factors such as sex, age, duration of illness, preoperative best corrected visual acuity, presence of underlying diseases, proliferative vitreoretinopathy, lattice degeneration, macular involvement, extent of retinal detachment at diagnosis, axial length, and myopia level to explore their impact on surgical outcomes.
Results:
The study included 122 eyes. The mean age was 23.81 ± 2.82 years, and the average sphere power was -5.80 ± 3.71 diopters (D). The percentage of eyes with a refraction of ≤ -6.0 D came to 44.3% (54/122), and with ≤ -4.0 D it amounted to 72.1% (88/122). The average logarithm of the minimum angle of resolution (logMAR) best corrected visual acuity improved significantly from 0.52 ± 0.68 before surgery to 0.28 ± 0.45 after surgery. The primary surgical success rates were 92.0% for scleral buckling, 88.9% for vitrectomy, and 92.3% for combined scleral buckling and vitrectomy, with no significant factors related to anatomical success identified.
Conclusions
There was a high prevalence of moderate to severe myopia among patients in their 20s with rhegmatogenous retinal detachment. However, no statistically significant correlation was found between the degree of myopia and anatomical success. Both functional and anatomical outcomes were generally favorable in these patients.
9.Clinical characterization of seven cases of sporadic Creutzfeldt-Jakob disease
Pankui LI ; Le CHANG ; Tingting YANG ; Jing ZHOU ; Yixin GU ; Zhenhai WANG
Chinese Journal of Experimental and Clinical Virology 2025;39(3):366-369
Objective:To analyze the clinical data of seven patients with a clinical diagnosis of likely sporadic Creutzfeldt-Jakob disease (sCJD) in order to improve the understanding and diagnosis of sporadic Creutzfeldt-Jakob disease.Methods:The clinical data of 7 sCJD patients admitted to the Department of Neurology of Our Hospital from 2021 to 2023 were retrospectively analyzed.Results:All seven patients had a subacute onset of disease, and the main clinical features included rapidly progressive dementia (RPD), cerebellar symptoms, pyramidal signs, myoclonus and akinetic mutism. Magnetic resonance diffusion-weighted imaging (DWI) reveals widespread asymmetrical lace-like high signal distributed along the cortex and a basal curved ball-and-stick sign. Electroencephalography (EEG) shows diffuse spiking and spiking slow waves, and periodic triphasic waves in advanced stages of the disease. Cerebrospinal fluid 14-3-3 protein testing was performed in 6 of the 7 patients, and 4 were positive. Four patients died within six months of onset of illness.Conclusions:The disease is prevalent in middle-aged and elderly patients, with a non-significant male-to-female ratio, and is dominated by the presence of Rapidly Progressive Dementia (RPD), especially the presence of cortical high signals in the DWI sequences and diffuse sharp and slow wave issuance in the electroencephalograph (EEG), which need to be alerted to the occurrence of Creutzfeldt-Jakob Disease. Dynamic review of MRI, EEG, cerebrospinal fluid 14-3-3 protein, prion protein gene (PRNP) sequence analysis and cerebrospinal fluid prion real-time vibration-induced protein amplification (RT-QuIC) monitoring whenever possible to avoid misdiagnosis, under-diagnosis, and under-recognition.
10.Prevalence and related factors of polypoid lesion of gallbladder of soldiers stationed on an island
Shuai XU ; Zhichao XU ; Yining LIU ; Mingli GU ; Chang SUN
Journal of Navy Medicine 2025;46(10):987-991
Objective To investigate the prevalence and influencing factors of polypoid lesion of gallbladder(PLG)of soldiers stationed on an island.Methods A total of 687 soldiers stationed on an island who underwent annual physical examination from October to December 2020 were selected.They took transabdominal ultrasound and blood biochemical examination,and filled out the questionnaire.There were 62 cases with PLG(PLG group)and 625 cases without PLG(non-PLG group).Age,body mass index(BMI),blood pressure,smoking,eating habits,blood biochemical indexes,and self-rating depression scale(SDS)scores were compared between the two groups.Logistic regression analysis was performed to obtain the independent risk factors for the prevalence of PLG of the soldiers.Results There were significant differences in age,BMI,blood pressure,smoking,irregular diet,total cholesterol(TC),triacylglycerol(TG),low-density lipoprotein cholesterol(LDL-C)and SDS scores between the two groups(all P<0.05).Multivariate Logistic regression analysis showed that age,high BMI,smoking,irregular diet,high TC,high TG,high LDL-C,and high SDS scores were independent risk factors for PLG(all P<0.05).Conclusion There is a high overall prevalence of PLG in the soldiers of this island,which is related to age,high BMI,smoking,irregular diet,high TC,high TG,high LDL-C,and high SDS scores.

Result Analysis
Print
Save
E-mail